Form 4: PAHC Exec Granted 2,152 Restricted Stock Units

Phibro Animal Health Corp. Senior VP Lisa Ann Escudero was granted 2,152 restricted stock units, vesting over three years.

Summary

• Lisa Ann Escudero, Senior Vice President of Human Resources at Phibro Animal Health Corp. (PAHC), acquired 2,152 Class A Common Stock equivalent Restricted Stock Units (RSUs).
• The transaction occurred on August 15, 2025.
• The RSUs were acquired at a price of $0, which is typical for equity grants.
• Following this transaction, Ms. Escudero directly beneficially owns 2,152 RSUs.
• These RSUs will vest in substantially equal installments on the first three anniversaries of August 1, 2025, contingent on her continued employment.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a key executive is a standard practice for aligning management incentives with shareholder interests, indicating stability in executive compensation strategy.

Positives

• The grant of 2,152 Restricted Stock Units to a Senior Vice President aligns management's interests with shareholder value.
• The vesting schedule over three years encourages long-term commitment and performance from the executive.

Risks

• The vesting of the Restricted Stock Units is subject to the Reporting Person's continued employment through the applicable vesting dates.

Future Outlook

The vesting of 2,152 Restricted Stock Units over the next three years, starting from August 1, 2025, indicates a long-term incentive for the Senior Vice President of Human Resources, aligning her future performance with company objectives.

Management Comments

• The reported securities represent restricted stock units ('RSUs'), each of which represents a contingent right to receive one share of Class A Common Stock.
• The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Industry Context

This executive compensation event is a common practice across various industries, including the animal health sector, where companies use equity grants to incentivize and retain key personnel.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice across various industries, including the animal health sector, for aligning executive incentives with long-term shareholder value.
• The vesting schedule over three years is a common structure for such equity awards, comparable to practices observed in companies like Zoetis Inc. (ZTS) or Elanco Animal Health Incorporated (ELAN), which also utilize time-based equity grants for their senior leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact due to enhanced alignment of executive incentives with long-term company performance and shareholder value.

Next Steps

• RSUs will vest in substantially equal installments on the first three anniversaries of August 1, 2025, contingent on continued employment.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to a senior executive, which is a standard component of executive compensation. It does not provide new information that would significantly alter the investment thesis or warrant a change in current holding strategy.

Keywords

Phibro Animal Health, PAHC, Restricted Stock Units, RSU, Executive Compensation, Stock Grant, Insider Transaction, Form 4